Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JMAR Technologies(JMAR) -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (6402)	8/17/1998 11:17:00 PM
From: Candle stick	Respond to of 9695

Business in the industry is picking up all of a sudden, per the Motley Fool evening news: "Shares of semiconductor capital equipment companies took off today after automated test equipment and electronic equipment backplane manufacturer Teradyne (NYSE: TER) announced that semiconductor fabrication company Taiwan Semiconductor Manufacturing (NYSE: TSM) has purchased "multiple" Catalyst test systems. As back-end test equipment is usually the first capital equipment to be added to a fabrication facility (fab) to increase output, this news and news of another order for Teradyne from another Taiwan merchant fab were greeted warmly by other semiconductor capital equipment manufacturers. Applied Materials (Nasdaq: AMAT) climbed $2 3/16 to $33 5/16 and Novellus (Nasdaq: NVLS) added $3 5/16 to $39 11/16. Today's news follows last week's large order for other types of assembly equipment from Kulicke & Soffa (Nasdaq: KLIC), which usually acts as one of the better barometers for the semiconductor and semiconductor capital equipment industry. Also moving today was KLA-Tencor (Nasdaq: KLAC), the leader in yield enhancement and process control equipment for the semiconductor industry. SoundView started coverage of the company with a "long-term buy" rating, estimating fiscal 2000 EPS of $1.74, well above the current IBES estimate of $1.58."

To: Starlight who wrote (6402)	8/18/1998 10:23:00 AM
From: Bucky Katt	Read Replies (1) \| Respond to of 9695

ES--How will this weigh on Jmar's product?>>TRANSMEDICA to Receive Vital New Patent for Laser Lancet LITTLE ROCK, Ark.--(BW HealthWire)--Aug. 18, 1998--TRANSMEDICA International, Inc. announced today that it has received a letter of allowance from the United States Patent Office that will secure its intellectual property position for the use of lasers in drawing capillary blood, and for the transdermal administration of pharmaceuticals. The new patent will protect the methods of use of the company's Laser Lancet(R). The Laser Lancet(R) has already received device patent protection. ''The patent office's letter of allowance secures our position as the only company with broad patented technology for capillary blood draws and laser-assisted transdermal drug delivery,'' said Charles Vestal, TRANSMEDICA's President, and Chief Executive Officer. ''Our ability to provide this technology is a significant benefit to both patients and health care workers,'' Vestal added. The TRANSMEDICA Laser Lancet(R) is the only patented laser device cleared by the U.S. Food and Drug Administration for all capillary blood draws for screening purposes. The Laser Lancet(R) eliminates the need for sharps to effect capillary blood draws, thereby making the procedure safer for patients and health care workers. TRANSMEDICA has many additional patent applications pending. ''Our research and development have demonstrated exciting and important new applications for our technology,'' said Vestal. ''We will be filing new patent applications, and we will continue to protect those already issued,'' he added. The Laser Lancet(R) is manufactured for TRANSMEDICA by LaBarge, Inc. (AMEX:LB - news), a St. Louis, MO firm that designs and manufactures high performance electronics for a variety of industries.